Critics say the Schedule I classification is heavy-handed, based on fear rather than evidence. “It bypasses science,” says Maritza Perez, a director at the Drug Policy Alliance, a non-profit focused on drug policy reform. Frustrated by this blanket ban, and eager to develop new overdose treatments, a growing number of scientists, doctors, and other researchers […]